Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low Dose Naltrexone (LDN) Therapy for Complex Regional Pain Syndrome (CRPS): A Feasibility Study

NCT06306157 is registered in ClinicalTrials.gov with Hospital for Special Surgery, New York as lead sponsor.

NCT NCT06306157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06306157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low Dose Naltrexone (LDN) Therapy for Complex Regional Pain Syndrome (CRPS): A Feasibility Study
Lead sponsor
Hospital for Special Surgery, New York
Phase
Phase 4
Overall status
Enrolling by invitation
Start date
January 2, 2024
Completion date
November 30, 2026
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

causalgia, chronic pain, complex regional pain syndrome, complex regional pain syndrome type i, complex regional pain syndrome type ii